Showing results (71-80 of 79) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Emerging Microbes & Infections|July 4, 2020
Profiles of COVID-19 clinical trials in the Chinese Clinical Trial RegistryPeng Xu, Xiangyu Xing, Keying Yu, et al.Cell Genomics|March 21, 2025
Cross-ancestry analyses of Chinese and European populations reveal insights into the genetic architecture and disease implication of metabolitesChenhao Lin, Mingfeng Xia, Yuxiang Dai, et al.Analytical Chemistry|March 3, 2026
High Coverage Quantitative Lipidomic Analysis for Multiple Biological Matrices Using Ultrahigh-Performance Liquid-Chromatography and Tandem Mass SpectrometryQinsheng Chen, Chenhan Zhang, Xiaoli Zhang, et al.Nature Aging|July 25, 2024
Gut microbial features and circulating metabolomic signatures of frailty in older adultsYanni Pu, Zhonghan Sun, Hui Zhang, et al.Journal of the American Heart Association|December 10, 2024
Metabonomic Biomarkers of Plaque Burden and Instability in Patients With Coronary Atherosclerotic Disease After Moderate Lipid-Lowering TherapyZhendong Mei, Lili Xu, Qingxia Huang, et al.Journal of Hepatology|October 18, 2024
A metabolome-derived score predicts metabolic dysfunction-associated steatohepatitis and mortality from liver diseaseQingxia Huang, Sami F Qadri, Hua Bian, et al.Alimentary Pharmacology & Therapeutics|January 13, 2022
NAFLD-related gene polymorphisms and all-cause and cause-specific mortality in an Asian population: the Shanghai Changfeng StudyMingfeng Xia, Shuai Ma, Qingxia Huang, et al.Diabetes|September 12, 2025
Multiomics Integration of Epigenetics, Proteomics, and Metabolomics Identifies Putative Drug Targets and Improves Early Prediction for DiabetesWenran Li, Yingyu Cheng, Aoyuan Cui, et al.The EMBO Journal|November 3, 2020
Blood molecular markers associated with COVID-19 immunopathology and multi-organ damageYan-Mei Chen, Yuanting Zheng, Ying Yu, et al.Pageof 8